CATALYST BIOSCIENCES, INC. Contracts & Agreements

Description of Securities (Filed With SEC on March 27, 2024)

Employment Agreement, dated January 15, 2024, by and between Han Ying, Ph.D. and Gyre Therapeutics, Inc (Filed With SEC on January 19, 2024)

Usman Separation Agreement (Filed With SEC on November 2, 2023)

Miller Separation Agreement (Filed With SEC on November 2, 2023)

Form of Warrant to Purchase Series X Convertible Preferred Stock (Filed With SEC on October 30, 2023)

Securities Purchase Agreement, dated October 27, 2023, by and between Catalyst and GNI USA (Filed With SEC on October 30, 2023)

Gyre Therapeutics, Inc. 2023 Omnibus Incentive Plan (Filed With SEC on October 30, 2023)

Form of Indemnification Agreement (Filed With SEC on October 30, 2023)

Wu Employment Agreement (Filed With SEC on October 30, 2023)

Chen Employment Agreement (Filed With SEC on October 30, 2023)

Second Amendment to Business Combination Agreement, dated as of August 30, 2023, by and among Catalyst, GNI USA, GNI Group, GNI HK, Shanghai Genomics and CPI (Filed With SEC on August 31, 2023)

Contingent Value Rights Agreement, dated as of December 26, 2022, between Catalyst and American Stock Transfer & Trust Company, LLC (Filed With SEC on August 14, 2023)

Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Nassim Usman, dated January 17, 2023 (Filed With SEC on August 14, 2023)

Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Grant Blouse, dated January 14, 2023 (Filed With SEC on August 14, 2023)

Waiver Agreement between Catalyst Biosciences, Inc. and Ms. Seline Miller, dated January 17, 2023 (Filed With SEC on August 14, 2023)

Contingent Value Rights Agreement, dated as of December 26, 2022, between Catalyst and American Stock Transfer & Trust Company, LLC (Filed With SEC on May 15, 2023)

Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Nassim Usman, dated January 17, 2023 (Filed With SEC on May 15, 2023)

Waiver Agreement between Catalyst Biosciences, Inc. and Dr. Grant Blouse, dated January 14, 2023 (Filed With SEC on May 15, 2023)

Waiver Agreement between Catalyst Biosciences, Inc. and Ms. Seline Miller, dated January 17, 2023 (Filed With SEC on May 15, 2023)

Amendment to Business Combination Agreement, dated as of March 29, 2023, by and among Catalyst, GNI USA, GNI Group, GNI HK, Shanghai Genomics, the Minority Holders and CPI (Filed With SEC on March 30, 2023)

Agreement and Amendment to Asset Purchase Agreement, dated as of March 29, 2023, by and among Catalyst, GNI Group and GNI HK (Filed With SEC on March 30, 2023)

Amendment to Contingent Value Rights Agreement, dated as of March 29, 2023, executed by Catalyst (Filed With SEC on March 30, 2023)

Asset Purchase Agreement dated as of February 27, 2023 by and between Catalyst Biosciences, Inc. and GC Biopharma Corp (Filed With SEC on March 2, 2023)

Asset Purchase Agreement, dated December 26, 2022, by and among Catalyst Biosciences, Inc., GNI Group Ltd., and GNI Hong Kong Limited (Filed With SEC on December 27, 2022)

Business Combination Agreement, dated December 26, 2022, by and among Catalyst Biosciences, Inc., GNI USA, Inc., GNI Group Ltd., GNI Hong Kong Limited, Shanghai Genomics, Inc.,... (Filed With SEC on December 27, 2022)

Catalyst Biosciences, Inc. Form of Director Indemnification Agreement (Filed With SEC on December 27, 2022)

Original Employment Agreement between Seline Miller and Catalyst Biosciences, Inc., dated November 4, 2021 (Filed With SEC on April 5, 2022)

Amendment to Original Employment Agreement between Seline Miller and Catalyst Biosciences, Inc., effective as of March 29, 2022 (Filed With SEC on April 5, 2022)

Form of Stock Option Award Agreement (Filed With SEC on March 31, 2022)

License Agreement, dated as of April 15, 2021, by and between SL 2T, LLC and Catalyst Biosciences, Inc (Filed With SEC on November 12, 2021)

Equity Distribution Agreement, dated as of October 15, 2021, between Catalyst Biosciences, Inc. and Piper Sandler & Co (Filed With SEC on October 15, 2021)

Consulting Agreement between Catalyst Biosciences, Inc. and Clinton Musil dated October 13, 2021 (Filed With SEC on October 13, 2021)

Consulting Agreement between Howard Levy and Catalyst Biosciences, Inc., dated August 15, 2021 (Filed With SEC on August 16, 2021)

License Agreement, dated as of April 15, 2021, by and between SL 2T, LLC and Catalyst Biosciences, Inc (Filed With SEC on August 5, 2021)

Original Employment Agreement between Grant Blouse and Catalyst Biosciences, Inc., dated August 27, 2018 (Filed With SEC on July 15, 2021)

Amendment to Original Employment Agreement between Grant Blouse and Catalyst Biosciences, Inc., effective as of July 1, 2021 (Filed With SEC on July 15, 2021)

Form of Stock Option Award Agreement (Filed With SEC on March 4, 2021)

Underwriting Agreement, dated January 26, 2021, by and between Catalyst Biosciences, Inc. and Piper Sandler & Co., as representative of the several Underwriters named therein (Filed With SEC on January 27, 2021)

Second Amendment to Office Lease, dated July 17, 2020, by and between 611 Gateway Center, L.P. and Catalyst Biosciences, Inc (Filed With SEC on November 5, 2020)

Offer Letter by and between Clinton Musil and Catalyst Biosciences, Inc. dated June 9, 2020 (Filed With SEC on November 5, 2020)

Amended and Restated Collaboration Agreement, dated May 8, 2020, by and between Mosaic Biosciences, Inc. and Catalyst Biosciences, Inc (Filed With SEC on August 6, 2020)

Underwriting Agreement, dated June 18, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters named... (Filed With SEC on June 19, 2020)

Description of Securities (Filed With SEC on February 20, 2020)

Amended and Restated Collaboration Agreement, dated December 18, 2019, by and between Mosaic Biosciences, Inc. and Catalyst Biosciences, Inc (Filed With SEC on February 20, 2020)

Description of Annual Cash Incentive Program (Filed With SEC on February 20, 2020)

License and Collaboration Agreement, dated December 18, 2019, by and between Biogen International GMBH and Catalyst Biosciences, Inc (Filed With SEC on February 20, 2020)

Underwriting Agreement, dated February 13, 2020, by and between Catalyst Biosciences, Inc. and Raymond James & Associates, Inc., as representative of the several Underwriters... (Filed With SEC on February 14, 2020)

Cooperation Agreement, effective as of January 13, 2020, between Catalyst Biosciences, Inc. and certain Investors specified therein (Filed With SEC on January 17, 2020)

Clinical Supply Agreement, effective as of October 4, 2019, by and between Catalyst Biosciences, Inc. and Catalent Indiana, LLC (Filed With SEC on October 15, 2019)

Amended and Restated License Agreement, dated December 13, 2018, by and between Catalyst and ISU Abxis (Filed With SEC on March 8, 2019)

Amended and Restated Employment Agreement, dated as of August 28, 2018, by and between the Company and Dr. Nassim Usman, Ph.D (Filed With SEC on August 31, 2018)

Amended and Restated Employment Agreement, dated as of August 29, 2018, by and between the Company and Dr. Howard Levy, M.B.B.Ch., Ph.D., M.M.M (Filed With SEC on August 31, 2018)

Amended and Restated Employment Agreement, dated as of August 30, 2018, by and between the Company and Mr. Fletcher Payne (Filed With SEC on August 31, 2018)

First Amendment to Office Lease, dated as of August 9, 2018, by and between BXP 611 Gateway Center, LP and the Company (Filed With SEC on August 15, 2018)

Offer Letter, executed April 15, 2016, by and between Catalyst and Dr. Howard Levy (Filed With SEC on March 19, 2018)

Underwriting Agreement, dated February 13, 2018, by and between the Company and JonesTrading Institutional Services LLC as representative for the several underwriters named therein (Filed With SEC on February 15, 2018)

Underwriting Agreement, dated December 20, 2017, by and between the Company and JonesTrading Institutional Services LLC as representative for the several underwriters named therein (Filed With SEC on December 22, 2017)

Lease Agreement, by and between BXP 611 Gateway Center, LP and the Company (Filed With SEC on November 17, 2017)

Amended and Restated Employment Agreement, dated as of September 19, 2017, by and between Catalyst Biosciences, Inc. and Dr. Nassim Usman, Ph.D (Filed With SEC on September 22, 2017)

Amended and Restated Employment Agreement, dated as of September 19, 2017, by and between Catalyst Biosciences, Inc. and Fletcher Payne (Filed With SEC on September 22, 2017)

CATALYST BIOSCIENCES, INC. (Formerly, Targacept, Inc.) 2015 STOCK INCENTIVE PLAN Incentive Stock Option Agreement (Employees) (Filed With SEC on July 14, 2017)

CATALYST BIOSCIENCES, INC. (Formerly, Targacept, Inc.) 2015 STOCK INCENTIVE PLAN Nonqualified Stock Option Agreement (Employees) (Filed With SEC on July 14, 2017)

930,000 SHARES OF COMMON STOCK, 13,350 SHARES OF SERIES A CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO 2,670,000 SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE INTO 1,800,000... (Filed With SEC on April 13, 2017)

SHARES OF COMMONSTOCK, SHARES OF SERIES ACONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLEINTO SHARES OF COMMON STOCK) OF CATALYST... (Filed With SEC on April 4, 2017)

COMMON STOCKPURCHASE WARRANT CATALYST BIOSCIENCES, INC. (Filed With SEC on April 4, 2017)

INDEMNIFICATION AGREEMENT (Filed With SEC on March 8, 2017)

TERMINATION AGREEMENT (Filed With SEC on March 8, 2017)

Separation Agreement and General Release of Claims (Filed With SEC on September 16, 2016)

DEVELOPMENT AND MANUFACTURING SERVICES AGREEMENT (Filed With SEC on August 4, 2016)

CATALYST BIOSCIENCES, INC. 2016 INDUCEMENT STOCK INCENTIVE PLAN CATALYST BIOSCIENCES, INC. 2016 INDUCEMENT STOCK INCENTIVE PLAN (Filed With SEC on April 20, 2016)

WARRANT TO PURCHASE STOCK (Filed With SEC on March 9, 2016)

WARRANT TO PURCHASE STOCK OF CATALYST BIOSCIENCES, INC. (Filed With SEC on March 9, 2016)

WARRANT TO PURCHASE STOCK OF CATALYSTBIOSCIENCES, INC. (Filed With SEC on March 9, 2016)

CATALYST BIOSCIENCES, INC. (Formerly, Targacept, Inc.) 2015 STOCK INCENTIVE PLAN (As Amended and Restated Effective October 14, 2015) CATALYST BIOSCIENCES, INC. (Formerly,... (Filed With SEC on November 5, 2015)

TARGACEPT, INC., asIssuer, and AMERICANSTOCK TRANSFER & TRUST COMPANY, LLC, Trustee Indenture Dated as ofAugust 19, 2015 Providing for the Issuance Of Redeemable Convertible... (Filed With SEC on September 4, 2015)

ESCROW AGREEMENT (Filed With SEC on September 4, 2015)

SUBLEASE AGREEMENT (Filed With SEC on May 22, 2015)

LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on May 22, 2015)

AMENDMENT NO. 1 TO LICENSE AND COLLABORATION AGREEMENT (Filed With SEC on May 22, 2015)

CATALYST BIOSCIENCES, INC. 2004 STOCK PLAN (Filed With SEC on May 22, 2015)

CATALYST BIOSCIENCES, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 22, 2015)

CATALYST BIOSCIENCES, INC. 260 Littlefield Avenue South San Francisco,CA 94080 p ###-###-#### f ###-###-#### www.catbio.com (Filed With SEC on May 22, 2015)

CATALYST BIOSCIENCES,INC. 260 Littlefield Avenue South San Francisco, CA 94080 p ###-###-#### f ###-###-#### www.catbio.com 1 (Filed With SEC on May 22, 2015)

*** CATALYST BIOSCIENCES, INC. 260 Littlefield Avenue South San Francisco, CA94080 p ###-###-#### f ###-###-#### www.catbio.com (Filed With SEC on May 22, 2015)

*** 1 (Filed With SEC on May 22, 2015)

CATALYST BIOSCIENCES, INC. CONSULTING AGREEMENT (Filed With SEC on May 22, 2015)

CATALYST BIOSCIENCES, INC. STOCK OPTION AGREEMENT EARLY EXERCISE (Filed With SEC on May 22, 2015)

AMENDMENT NO. 2 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on May 14, 2015)

AMENDED AND RESTATED VOTING AGREEMENT among: TARGACEPT,INC., a Delaware corporation; CATALYST BIOSCIENCES, INC. a Delaware corporation; and the undersigned Stockholder Dated as... (Filed With SEC on May 14, 2015)

AMENDED AND RESTATED VOTING AGREEMENT among: CATALYSTBIOSCIENCES, INC., a Delaware corporation; TARGACEPT, INC., aDelaware corporation; and the undersigned Stockholder Dated as of... (Filed With SEC on May 14, 2015)

AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER (Filed With SEC on May 12, 2015)

TARGACEPT, INC. 2006STOCK INCENTIVE PLAN Restricted Stock Award Agreement (Filed With SEC on March 16, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on March 16, 2015)

AGREEMENT AND PLAN OF MERGER among: TARGACEPT,INC., a Delaware corporation; TALOS MERGER SUB, INC., a Delaware corporation; and CATALYST BIOSCIENCES, INC., a Delaware corporation... (Filed With SEC on March 6, 2015)

VOTING AGREEMENT among: TARGACEPT,INC., a Delaware corporation; CATALYST BIOSCIENCES, INC. a Delaware corporation; and the undersigned Stockholder Dated as ofMarch 5, 2015 TABLE... (Filed With SEC on March 6, 2015)

VOTING AGREEMENT among: CATALYSTBIOSCIENCES, INC., a Delaware corporation; TARGACEPT, INC., aDelaware corporation; and the undersigned Stockholder Dated as of March 5, 2015 TABLE... (Filed With SEC on March 6, 2015)

LOCK-UP AGREEMENT (Filed With SEC on March 6, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on December 16, 2014)

CERTAIN CONFIDENTIAL MATERIAL APPEARING IN THIS DOCUMENT, MARKED BY [********], HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE... (Filed With SEC on March 14, 2014)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on January 28, 2014)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on January 28, 2014)

TARGACEPT, INC. CommonStock (par value $0.001 per share) At-the-Market Issuance Sales Agreement (Filed With SEC on November 26, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on November 6, 2013)

TARGACEPT, INC. 2006STOCK INCENTIVE PLAN Nonqualified Stock Option Agreement (Nonemployee Directors) (Filed With SEC on November 6, 2013)

TRANSITION SERVICES AGREEMENT (Filed With SEC on August 14, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on August 7, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on June 28, 2013)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on May 8, 2013)

AMENDMENT NO. 5 TO COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (Filed With SEC on May 8, 2013)

SUBLEASE Between B/E AEROSPACE, INC., a Delaware corporation Sublandlord, and TARGACEPT, INC., a Delaware corporation, Subtenant. Dated: December 4, 2012 1 TABLE OF CONTENTS (Filed With SEC on March 15, 2013)

TARGACEPT, INC. 2006 STOCK INCENTIVE PLAN (As Amended and Restated ThroughMarch 9, 2011) TARGACEPT, INC. 2006 STOCK INCENTIVE PLAN (As Amended and Restated Through March 9, 2011) (Filed With SEC on March 15, 2013)

TARGACEPT, INC. RETENTION AWARD AGREEMENT (Filed With SEC on March 15, 2013)

Description of Annual Cash Incentive Program (Filed With SEC on March 15, 2013)

Description of Non-Employee Director Compensation Program (Filed With SEC on March 15, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on November 16, 2012)

WITNESSETH: (Filed With SEC on November 8, 2012)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on August 9, 2012)

TRANSITION SERVICES AGREEMENT (Filed With SEC on June 6, 2012)

WITNESSETH: (Filed With SEC on March 6, 2012)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 6, 2012)

Targacept, Inc. Common Stock ($0.001 Par Value) EQUITY UNDERWRITING AGREEMENT (Filed With SEC on May 20, 2011)

TARGACEPT, INC. 2006 STOCK INCENTIVE PLAN (As Amended and Restated ThroughMarch 9, 2011) TARGACEPT, INC. 2006 STOCK INCENTIVE PLAN (As Amended and Restated Through March 9, 2011) (Filed With SEC on March 11, 2011)

EXCLUSIVE LICENSE AGREEMENT BETWEEN CORNERSTONE THERAPEUTICS INC. AND TARGACEPT, INC. TABLE OF CONTENTS (Filed With SEC on March 11, 2011)

Description of Annual Cash Incentive Program (Filed With SEC on March 11, 2011)

AMENDMENT NO. 4 TO COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (Filed With SEC on November 5, 2010)

AMENDMENT NO.3 TO COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (Filed With SEC on August 9, 2010)

WITNESSETH: (Filed With SEC on August 9, 2010)

($21,862.83/month) (Filed With SEC on March 11, 2010)

COMMENTS (Filed With SEC on March 11, 2010)

AMENDED AND RESTATEDSUPPLY AGREEMENT entered into effective as of the date of the last party to sign below(hereinafter referred to as the Effective Date) by and among (Filed With SEC on March 11, 2010)

BETWEEN ASTRAZENECA AB (Filed With SEC on March 11, 2010)

Description of Annual Cash Incentive Program (Filed With SEC on March 11, 2010)

Description of Non-Employee Director Compensation Program (Filed With SEC on March 11, 2010)

AMENDMENT NO. 2 TO (Filed With SEC on November 6, 2009)

2,200,000 Shares Targacept, Inc. (Filed With SEC on October 9, 2009)

[Targacept Letterhead] (Filed With SEC on August 7, 2009)

SUPPLY AGREEMENT (Filed With SEC on March 13, 2009)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2008)

AMENDMENT NO. 2 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2008)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2008)

EMPLOYMENT AGREEMENT (Filed With SEC on May 8, 2008)

TARGACEPT, INC. 2006 STOCK INCENTIVE PLAN (Filed With SEC on March 14, 2008)

AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENT (Filed With SEC on March 14, 2008)

ASSET PURCHASE AND TRADEMARK ASSIGNMENT AGREEMENT (Filed With SEC on March 14, 2008)

LOAN AGREEMENT (Filed With SEC on March 12, 2008)

3,800,000 Shares Targacept, Inc. Common Stock ($0.001 Par Value) (Filed With SEC on January 18, 2008)

PRODUCT DEVELOPMENT AND (Filed With SEC on November 9, 2007)

STOCK PURCHASE AGREEMENT BY AND BETWEEN TARGACEPT, INC. AND GLAXO GROUP LIMITED DATED AS OF JULY 27, 2007 STOCK PURCHASE AGREEMENT (Filed With SEC on November 9, 2007)

MASTER CLINICAL SERVICES AGREEMENT between TARGACEPT, INC. and FORENAP PHARMA EURL Page 1 / 33 (Filed With SEC on November 9, 2007)

2007 Declaration of Amendment to the Targacept, Inc. 2006 Stock Incentive Plan (Filed With SEC on August 8, 2007)

WITNESSETH: (Filed With SEC on March 22, 2007)

EXCLUSIVE LICENSE AGREEMENT (Filed With SEC on March 22, 2007)

Responsibility (Architect, Owner orNot Provided) (Filed With SEC on March 22, 2007)

List of Exhibits (Filed With SEC on March 22, 2007)

Description of Annual Cash Incentive Program (Filed With SEC on March 22, 2007)

Description of Non-Employee Director Compensation Program (Filed With SEC on March 22, 2007)

AMENDMENT NO. 1 TO COLLABORATIVE RESEARCH AND LICENSE AGREEMENT (Filed With SEC on November 13, 2006)

WITNESSETH: (Filed With SEC on August 11, 2006)

Second Amended and Restated Note and Security Agreement (Filed With SEC on July 7, 2006)

Third Amended and RestatedInvestor Rights Agreement (Filed With SEC on March 24, 2006)

TARGACEPT, INC. (Filed With SEC on March 16, 2006)

PRODUCTION COORDINATOR: TODD DEROSSETT ###-###-#### (Filed With SEC on March 16, 2006)

WITNESSETH THAT: (Filed With SEC on March 16, 2006)

2000 EQUITY INCENTIVE PLAN (Filed With SEC on March 16, 2006)

TARGACEPT, INC. 2006 STOCK INCENTIVE PLAN TARGACEPT, INC. (Filed With SEC on March 16, 2006)

2006 STOCK INCENTIVE PLAN Incentive Stock Option Agreement (Filed With SEC on March 16, 2006)

2006 STOCK INCENTIVE PLAN Nonqualified Stock Option Agreement (Filed With SEC on March 16, 2006)

2006 STOCK INCENTIVE PLAN Restricted Stock Award Agreement (Filed With SEC on March 16, 2006)

THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 17, 2006)

Amendment No. 1 to (Filed With SEC on January 17, 2006)

TARGACEPT, INC. WARRANT TO PURCHASE COMMON STOCK August 22, 2000 (Filed With SEC on January 17, 2006)

WITNESSETH: (Filed With SEC on January 17, 2006)

LOAN AGREEMENT (Filed With SEC on January 17, 2006)

Amended and Restated Note and Security Agreement (Filed With SEC on January 17, 2006)

2000 EQUITY INCENTIVE PLAN (Filed With SEC on January 17, 2006)

2000 EQUITY INCENTIVE PLAN OF TARGACEPT, INC. Stock Option Agreement (Employees) (Filed With SEC on January 17, 2006)

2000 EQUITY INCENTIVE PLAN OF TARGACEPT, INC. Stock Option Agreement (Non-Employee Directors) (Filed With SEC on January 17, 2006)

2000 EQUITY INCENTIVE PLAN OF TARGACEPT, INC. Restricted Stock Award Agreement (Service-Based Award) (Filed With SEC on January 17, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on January 17, 2006)

COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between (Filed With SEC on January 17, 2006)

AMENDED AND RESTATED COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between (Filed With SEC on January 17, 2006)

Telephone ###-###-#### Fascsimile ###-###-#### E-mail ***@*** (Filed With SEC on January 17, 2006)

ASSET PURCHASE AGREEMENT (Filed With SEC on January 17, 2006)

ASSET PURCHASE AND TRADEMARK ASSIGNMENT AGREEMENT (Filed With SEC on January 17, 2006)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on January 17, 2006)

LICENSE AGREEMENT (Filed With SEC on January 17, 2006)

Development and Production Agreement For (Filed With SEC on January 17, 2006)

PRODUCTION COORDINATOR: TODD DEROSSETT ###-###-#### (Filed With SEC on February 22, 2005)

INDEMNIFICATION AGREEMENT (Filed With SEC on February 22, 2005)

2000 EQUITY INCENTIVE PLAN OF TARGACEPT, INC. Stock Option Agreement (Employees) (Filed With SEC on February 22, 2005)

2000 EQUITY INCENTIVE PLAN OF TARGACEPT, INC. Stock Option Agreement (Non-Employee Directors) (Filed With SEC on February 22, 2005)

2000 EQUITY INCENTIVE PLAN (Filed With SEC on February 22, 2005)

TARGACEPT, INC. (Filed With SEC on February 22, 2005)

TARGACEPT, INC. 2005 STOCK INCENTIVE PLAN Incentive StockOption Agreement (Employees) (Filed With SEC on February 22, 2005)

TARGACEPT, INC. 2005 STOCK INCENTIVE PLAN Nonqualified StockOption Agreement (Employees) (Filed With SEC on February 22, 2005)

TARGACEPT, INC. 2005 STOCK INCENTIVE PLAN Nonqualified StockOption Agreement (Nonemployee Directors) (Filed With SEC on February 22, 2005)

TARGACEPT, INC. (Filed With SEC on February 22, 2005)

TARGACEPT, INC. (Filed With SEC on February 4, 2005)

THIRD AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (Filed With SEC on January 20, 2005)

Amendment No. 1 to (Filed With SEC on January 20, 2005)

WITNESSETH: (Filed With SEC on January 20, 2005)

Amendment No. 1 to (Filed With SEC on December 15, 2004)

CONVERTIBLEPROMISSORY NOTE (Filed With SEC on December 15, 2004)

AMENDED AND RESTATED COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between (Filed With SEC on December 15, 2004)

COLLABORATIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on December 15, 2004)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on December 15, 2004)

LICENSE AGREEMENT between MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE,INC. and (Filed With SEC on December 15, 2004)

LICENSE AGREEMENT (Filed With SEC on December 15, 2004)

Development and Production Agreement For (Filed With SEC on December 15, 2004)

DEVELOPMENT AGREEMENT (Filed With SEC on December 15, 2004)

TARGACEPT, INC. WARRANT TO PURCHASE COMMON STOCK August 22, 2000 (Filed With SEC on May 14, 2004)

LOAN AGREEMENT (Filed With SEC on May 14, 2004)

Amended and Restated Note and Security Agreement (Filed With SEC on May 14, 2004)

2000 EQUITY INCENTIVE PLAN (Filed With SEC on May 14, 2004)

EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2004)

COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between (Filed With SEC on May 14, 2004)

AMENDED AND RESTATED COLLABORATIVE RESEARCH AND LICENSE AGREEMENT between (Filed With SEC on May 14, 2004)

Telephone ###-###-#### Fascsimile ###-###-#### E-mail ***@*** (Filed With SEC on May 14, 2004)

COLLABORATIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on May 14, 2004)

ASSET PURCHASE AGREEMENT (Filed With SEC on May 14, 2004)

ASSET PURCHASE AND TRADEMARK ASSIGNMENT AGREEMENT (Filed With SEC on May 14, 2004)

AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on May 14, 2004)

LICENSE AGREEMENT (Filed With SEC on May 14, 2004)

LICENSE AGREEMENT between MEDICAL COLLEGE OF GEORGIA RESEARCH INSTITUTE,INC. and (Filed With SEC on May 14, 2004)

LICENSE AGREEMENT (Filed With SEC on May 14, 2004)

Development and Production Agreement For (Filed With SEC on May 14, 2004)

Category

Industry

Companies

Contracts

CATALYST BIOSCIENCES, INC. Contracts & Agreements